Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Ingmar Mederacke; Christine C. Hsu; Juliane S. Troeger; Peter Huebener; Xueru Mu; Dianne H. Dapito; Jean-Philippe Pradere; Robert F. Schwabe

doi:10.1038/ncomms3823

journal article Nov 22, 2013

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Ingmar Mederacke

Christine C. Hsu Juliane S. Troeger Peter Huebener Xueru Mu Dianne H. Dapito Jean-Philippe Pradere Robert F. Schwabe

Nature Communications Vol. 4 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/ncomms3823

Topics

No keywords indexed for this article. Browse by subject →

References

55

[1]

Mehal, W. Z., Iredale, J. & Friedman, S. L. Scraping fibrosis: expressway to the core of fibrosis. Nat. Med. 17, 552–553 (2011). 10.1038/nm0511-552

[2]

Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500–503 (2003). 10.1002/path.1427

[3]

Wynn, T. A. & Ramalingam, T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028–1040 (2012). 10.1038/nm.2807

[4]

Bataller, R. & Brenner, D. A. Liver fibrosis. J. Clin. Invest. 115, 209–218 (2005). 10.1172/jci24282

[5]

Dranoff, J. A. & Wells, R. G. Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 51, 1438–1444 (2010). 10.1002/hep.23405

[6]

Iwaisako, K., Brenner, D. A. & Kisseleva, T. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J. Gastroenterol. Hepatol. 27, 65–68 (2012). 10.1111/j.1440-1746.2011.07002.x

[7]

Perepelyuk, M. et al. Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G605–G614 (2013). 10.1152/ajpgi.00222.2012

[8]

Kisseleva, T. et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45, 429–438 (2006). 10.1016/j.jhep.2006.04.014

[9]

Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655–1669 (2008). 10.1053/j.gastro.2008.03.003

[10]

De Minicis, S. et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 132, 1937–1946 (2007). 10.1053/j.gastro.2007.02.033

[11]

Friedman, S. L., Roll, F. J., Boyles, J. & Bissell, D. M. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc. Natl Acad. Sci. USA 82, 8681–8685 (1985). 10.1073/pnas.82.24.8681

[12]

Kisseleva, T. et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl Acad. Sci. USA 109, 9448–9453 (2012). 10.1073/pnas.1201840109

[13]

Scholten, D. et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 139, 987–998 (2010). 10.1053/j.gastro.2010.05.005

[14]

Taura, K. et al. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51, 1027–1036 (2010). 10.1002/hep.23368

[15]

Chu, A. S. et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 53, 1685–1695 (2011). 10.1002/hep.24206

[16]

Li, Y., Wang, J. & Asahina, K. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc. Natl Acad. Sci. USA 110, 2324–2329 (2013). 10.1073/pnas.1214136110

[17]

Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125–172 (2008). 10.1152/physrev.00013.2007

[18]

Yang, L. et al. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 26, 2104–2113 (2008). 10.1634/stemcells.2008-0115

[19]

Michelotti, G. A. et al. Smoothened is a master regulator of adult liver repair. J. Clin. Invest. 123, 2380–2394 (2013).

[20]

Blaner, W. S. et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 1791, 467–473 (2009). 10.1016/j.bbalip.2008.11.001

[21]

Nagatsuma, K. et al. Lecithin: retinol acyltransferase protein is distributed in both hepatic stellate cells and endothelial cells of normal rodent and human liver. Liver Int. 29, 47–54 (2009). 10.1111/j.1478-3231.2008.01773.x

[22]

Yata, Y. et al. DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology 37, 267–276 (2003). 10.1053/jhep.2003.50067

[23]

Buch, T. et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419–426 (2005). 10.1038/nmeth762

[24]

Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193–215 (2011). 10.1016/j.devcel.2011.07.001

[25]

Asahina, K., Zhou, B., Pu, W. T. & Tsukamoto, H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology 53, 983–995 (2011). 10.1002/hep.24119

[26]

Russo, F. P. et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130, 1807–1821 (2006). 10.1053/j.gastro.2006.01.036

[27]

Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324–1332 (2007). 10.1038/nm1663

[28]

Higashiyama, R. et al. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 137, 1459–1466 e1451 (2009). 10.1053/j.gastro.2009.07.006

[29]

Sancho-Bru, P. et al. Genomic and functional characterization of stellate cells isolated from human cirrhotic livers. J. Hepatol. 43, 272–282 (2005). 10.1016/j.jhep.2005.02.035

[30]

Therapy for Fibrotic Diseases: Nearing the Starting Line

Scott L. Friedman, Dean Sheppard, Jeremy S. Duffield et al.

Science Translational Medicine 2013 10.1126/scitranslmed.3004700

[31]

Schuppan, D. & Kim, Y. O. Evolving therapies for liver fibrosis. J. Clin. Invest. 123, 1887–1901 (2013). 10.1172/jci66028

[32]

Schuppan, D. & Pinzani, M. Anti-fibrotic therapy: lost in translation? J. Hepatol. 56, (Suppl 1): S66–S74 (2012). 10.1016/s0168-8278(12)60008-7

[33]

Trauner, M., Fickert, P. & Wagner, M. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin. Liver Dis. 27, 77–98 (2007). 10.1055/s-2006-960172

[34]

Espanol-Suner, R. et al. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 143, 1564–1575 e1567 (2012). 10.1053/j.gastro.2012.08.024

[35]

Malato, Y. et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J. Clin. Invest. 121, 4850–4860 (2011). 10.1172/jci59261

[36]

Zaret, K. S. & Grompe, M. Generation and regeneration of cells of the liver and pancreas. Science 322, 1490–1494 (2008). 10.1126/science.1161431

[37]

Lujambio, A. et al. Non-cell-autonomous tumor suppression by p53. Cell 153, 449–460 (2013). 10.1016/j.cell.2013.03.020

[38]

Hernandez-Gea, V. et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142, 938–946 (2012). 10.1053/j.gastro.2011.12.044

[39]

Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85–97 (2010). 10.2353/ajpath.2010.090517

[40]

Hung, C. et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 188, 820–830 (2013). 10.1164/rccm.201212-2297oc

[41]

A Pericyte Origin of Spinal Cord Scar Tissue

Christian Göritz, David O. Dias, Nikolay Tomilin et al.

Science 2011 10.1126/science.1203165

[42]

Lebleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047–1053 (2013). 10.1038/nm.3218

[43]

Rock, J. R. et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc. Natl Acad. Sci. USA 108, E1475–E1483 (2011). 10.1073/pnas.1117988108

[44]

Zhuo, L. et al. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31, 85–94 (2001). 10.1002/gene.10008

[45]

Garcia, A. D., Doan, N. B., Imura, T., Bush, T. G. & Sofroniew, M. V. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 7, 1233–1241 (2004). 10.1038/nn1340

[46]

A robust and high-throughput Cre reporting and characterization system for the whole mouse brain

Linda Madisen, Theresa A Zwingman, Susan M Sunkin et al.

Nature Neuroscience 2010 10.1038/nn.2467

[47]

Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis. 45, 593–605 (2007). 10.1002/dvg.20335

[48]

Popov, Y., Patsenker, E., Fickert, P., Trauner, M. & Schuppan, D. Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J. Hepatol. 43, 1045–1054 (2005). 10.1016/j.jhep.2005.06.025

[49]

Troeger, J. S. et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143, 1073–1083 e1022 (2012). 10.1053/j.gastro.2012.06.036

[50]

Mitchell, C. & Willenbring, H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 3, 1167–1170 (2008). 10.1038/nprot.2008.80

Showing 50 of 55 references

Cited By

1,208

In vitro Host-Parasite Models Combined With Proteomics Reveal Cell Type-Specific Responses of Early Migrating Fasciola hepatica Juveniles

Marta López-García, Krystyna Cwiklinski · 2026

Molecular & Cellular Proteomics

Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis

Eva Novoa, Tamara Parracho · 2026

Cell Metabolism

Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease

Robert F. Schwabe, Frank Tacke · 2025

JHEP Reports

Tension-induced directional migration of hepatic stellate cells potentially coordinates liver fibrosis progression

Lyu Zhou, Ziao Shi · 2025

Nature Biomedical Engineering

Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy

Aigul Sharip, Jeannette Kunz · 2025

Cells

Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy

Hélène Gilgenkrantz, Rola Al Sayegh · 2025

Annual Review of Pharmacology and T...

The multi-faceted immune modulatory role of S100A4 in cancer and chronic inflammatory disease

Thomas Wong, Reece Kang · 2025

Frontiers in Immunology

Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer

Laura Sererols-Viñas, Gemma Garcia-Vicién · 2025

Seminars in Liver Disease

Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma

Silvia Affὸ, Laura Sererols-Viñas · 2025

The American Journal of Pathology

Nuclear Pirin promotes HCC by acting as a key inflammation-facilitating factor

Huanhuan Ma, Tingyan Cao · 2025

Gut

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies

Maurizio Parola, Massimo Pinzani · 2024

Molecular Aspects of Medicine

The Origin and Fate of Liver Myofibroblasts

Hyun Young Kim, Sadatsugu Sakane · 2024

Cellular and Molecular Gastroentero...

Serological Exosome Metabolic Biopsy of Hepatocellular Carcinoma via Designed Core–Shell Nanoparticles

Chenyu Yang, Haolin Chen · 2024

Analytical Chemistry

Immunologic landscape of human hepatic hemangiomas and epithelioid hemangioendotheliomas

Stefan Thomann, Thomas Metzler · 2024

Hepatology Communications

Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease

Valentin Blank, Thomas Karlas · 2024

Liver International

GARP on hepatic stellate cells is essential for the development of liver fibrosis

Xiaolong Zhang, Pankaj Sharma · 2023

Journal of Hepatology

Liver endothelial cells in NAFLD and transition to NASH and HCC

Rallia-Iliana Velliou, Aigli-Ioanna Legaki · 2023

Experientia

Hepatic inflammatory responses in liver fibrosis

Linda Hammerich, Frank Tacke · 2023

Nature Reviews Gastroenterology &am...

The chromatin remodeling protein BRG1 regulates HSC-myofibroblast differentiation and liver fibrosis

Yuwen Zhu, Aoqi Kang · 2023

Cell Death & Disease

Friend or foe? The elusive role of hepatic stellate cells in liver cancer

Bruno Cogliati, Chittampalli N. Yashaswini · 2023

Nature Reviews Gastroenterology &am...

Metrics

1,208

Citations

55

References

Details

Published: Nov 22, 2013
Vol/Issue: 4(1)
License: View

Authors

Jean-Philippe Pradere

R

Robert F. Schwabe

Cite This Article

Ingmar Mederacke, Christine C. Hsu, Juliane S. Troeger, et al. (2013). Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nature Communications, 4(1). https://doi.org/10.1038/ncomms3823

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

You May Also Like